wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36618010-95CE0479-ECA9-41D3-AF5B-8AF75BE338D3
Q36618010-95CE0479-ECA9-41D3-AF5B-8AF75BE338D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36618010-95CE0479-ECA9-41D3-AF5B-8AF75BE338D3
Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin
P2860
Q36618010-95CE0479-ECA9-41D3-AF5B-8AF75BE338D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36618010-95CE0479-ECA9-41D3-AF5B-8AF75BE338D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e86d0d89e9884fdebe95d35b81a4bd528f8224d0
P2860
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.